The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study to evaluate safety, tolerability, pharmacokinetics and activity of oraxol in patients (pts) with advanced malignancies.
 
Wen Wee Ma
Consulting or Advisory Role - Merrimack
Research Funding - Athenex (Inst); Merrimack (Inst)
 
Nilofer Saba Azad
Honoraria - AMAG Pharmaceuticals; Bayer/Onyx
Consulting or Advisory Role - AMAG Pharmaceuticals; Dava Oncology
Research Funding - Agios (Inst); Array BioPharma (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Intensity Therapeutics; Merck (Inst); Syndax (Inst)
 
Elaine Tat Lam
Honoraria - Astellas Oncology
Consulting or Advisory Role - Calithera Biosciences
Research Funding - Advaxis (Inst); Argos Therapeutics (Inst); Astellas Oncology (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Genentech (Inst); Janssen (Inst); Merck (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche (Inst)
 
Jennifer Robinson Diamond
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Casi Pharmaceuticals (Inst); Genentech/Roche (Inst); MedImmune (Inst); Millennium (Inst); OncoMed (Inst); Rexahn Pharmaceuticals (Inst); Scripps Hospital (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Takeda; Takeda
 
Grace K. Dy
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); OncoMed (Inst)
 
Mateusz Opyrchal
Consulting or Advisory Role - AstraZeneca
Research Funding - Pfizer
 
Denise Gallagher
No Relationships to Disclose
 
Caden Brennen
No Relationships to Disclose
 
David Cutler
Employment - Athenex
Stock and Other Ownership Interests - Athenex
 
Douglas Kramer
Employment - Athenex
 
Wing Kai Chan
Employment - Kinex
Stock and Other Ownership Interests - Athenex
Travel, Accommodations, Expenses - Athenex
 
Rudolf Kwan
Employment - Athenex
Leadership - Athenex
Stock and Other Ownership Interests - Athenex
Honoraria - Athenex
Consulting or Advisory Role - Athenex
Patents, Royalties, Other Intellectual Property - Athenex
Travel, Accommodations, Expenses - Athenex
 
Gerald J. Fetterly
Employment - Athenex
Leadership - Athenex
Stock and Other Ownership Interests - Athenex
Travel, Accommodations, Expenses - Athenex
 
Alex A. Adjei
No Relationships to Disclose
 
Antonio Jimeno
Research Funding - Acerta Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Celldex (Inst); Karyopharm Therapeutics (Inst); Kinex (Inst); MedImmune (Inst); Merck (Inst); OncoMed (Inst); Pfizer (Inst); Roche (Inst)